| Issuer / Guarantor | Arrowhead Pharmaceuticals Inc |
|---|---|
| Size | USD 700mn |
| Type | Convertible |
| Leads | JP Morgan, Jefferies, BoA, Piper Sandler, RBC |
| Maturity | 15 Jan 2032 (6 years) |
| Coupon | 0% (0.5 - 1%) |
| Premium | 35% (30 - 35%) |
| Calls | NC3; PC @ 130% w table MW |
| Puts | t/o @ 100% |
| Div protection | Ratio adjustment (Full) |
| T/o protection | Make-whole table |
| CoCo | 130% to Oct 2031 (5.8 yrs) |
| Announced | 06 Jan 2026 |